Sagimet Biosciences Inc. (SGMT) analyst actions
Rating and price-target actions on SGMT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SGMT overview →
1 measured SGMT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024 | Press release | +2.62% | -4.43% |
Keep exploring
More SGMT: earnings → · SEC filings → · SGMT overview →